This study aims to evaluate the effectiveness of a therapeutic exercise program designed specifically for women with breast cancer. The program includes general exercises along with specific movements for the upper limb to help reduce common side effects of cancer treatment such as lymphedema (swelling of the arm) and neuropathy (nerve pain or numbness). Participants will undergo the exercise program and be assessed before and after to determine improvements in their symptoms and overall quality of life. The goal is to provide evidence that targeted physical therapy can improve recovery and well-being in breast cancer survivors.
Patients receiving treatment for breast carcinoma.reatments include surgical procedures (breast-conserving surgery or mastectomy), axillary lymph node dissection, sentinel lymph node biopsy, radiotherapy, chemotherapy, and hormone therapy.
Participants must provide authorization from their primary care physician and/or oncologist to perform therapeutic exercise.
Diagnosis of lymphedema associated with stage I or II breast cancer (Stage 1 or mild: circumference difference less than 4 cm [volume difference 10-25%] compared to the healthy arm; Stage 2 or moderate: circumference difference between 4 and 6 cm [volume difference 25-50%] compared to the healthy arm).
A score of 4 or higher on the DN4 questionnaire (neuropathic pain)
Lack of medical authorization.
Pre-existing cardiac pathology prior to cancer diagnosis.
Exacerbation of comorbidities.
Travel time exceeding 45 minutes to the location where the therapeutic exercise program is conducted.
Universitat Internacional de Catalunya
Lead sponsor
Consorci Sanitari de Terrassa
Collaborator